Screener
AbCellera Biologics Inc. ABCL Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
| Line item | December 31, 2025 | June 30, 2026 |
|---|---|---|
| Total liabilities | 390,046 | 411,555 |
| Commitments and contingencies | ||
| Shareholders' equity: | ||
| Common shares: no par value, unlimited authorized shares at December 31, 2025 and June 30, 2026: 300,600,710 and 306,469,632 shares issued and outstanding at December 31, 2025 and June 30, 2026, respectively | 802,341 | 821,242 |
| Additional paid-in capital | 198,279 | 206,004 |
| Accumulated other comprehensive loss | (4,234) | (3,152) |
| Accumulated deficit | (29,482) | (128,074) |
| Total shareholders' equity | 966,904 | 896,020 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s common stock?
- AbCellera Biologics Inc. (ABCL) reported common stock of $821.24M in Q2 2026.
- How has AbCellera Biologics Inc.'s common stock changed year-over-year?
- AbCellera Biologics Inc.'s common stock increased by 3.7% year-over-year, from $791.67M to $821.24M.
- What is the long-term trend for AbCellera Biologics Inc.'s common stock?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s common stock has grown at a 2.5% compound annual growth rate (CAGR), from $710.39M to $802.34M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about AbCellera Biologics Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude